Electromed, Inc.

Equities

ELMD

US2854091087

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
16.39 USD +4.26% Intraday chart for Electromed, Inc. +13.82% +50.23%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Electromed, Inc., Q2 2024 Earnings Call, Feb 13, 2024
Electromed, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Electromed Signs Distribution Deal With Marathon Medical MT
Electromed, Inc. Announces Partnership to Expand Smartvest Access to Veterans, Federal Employees, and Native American Communities CI
Electromed Insider Bought Shares Worth $302,369, According to a Recent SEC Filing MT
Electromed, Inc. Renews Its $2,500,000 Revolving Line of Credit with Choice Financial Group CI
Transcript : Electromed, Inc., Q1 2024 Earnings Call, Nov 07, 2023
Tranche Update on Electromed, Inc.'s Equity Buyback Plan announced on May 27, 2021. CI
Electromed, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Electromed, Inc. Announces Launch of SmartVest Clearway Airway Clearance System CI
Transcript : Electromed, Inc., Q4 2023 Earnings Call, Aug 22, 2023
Tranche Update on Electromed, Inc.'s Equity Buyback Plan announced on May 27, 2021. CI
Electromed, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Electromed, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
North American Morning Briefing : Stock Futures -2- DJ
Electromed Appoints Jim Cunniff as President, Chief Executive MT
Electromed, Inc. Announces Appointment of Jim Cunniff as Its New President and Board of Director, Effective July 1, 2023 CI
Electromed Appoints Jim Cunniff as Chief Executive Officer, Effective July 1, 2023 CI
Transcript : Electromed, Inc., Q3 2023 Earnings Call, May 09, 2023
Tranche Update on Electromed, Inc.'s Equity Buyback Plan announced on May 27, 2021. CI
Electromed, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Electromed's Chief Executive Kathleen Skarvan to Retire in July MT
Transcript : Electromed, Inc., Q2 2023 Earnings Call, Feb 14, 2023
Tranche Update on Electromed, Inc.'s Equity Buyback Plan announced on May 27, 2021. CI
Electromed, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Chart Electromed, Inc.
More charts
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.39 USD
Average target price
26 USD
Spread / Average Target
+58.63%
Consensus